Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

55.45 +1.13 (+2.08%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
65 66 Next >
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These companies have the therapies to boost revenue for a decade. 
Via The Motley Fool
Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
From Bristol Myers Squibb
Via Business Wire
3 Buffett-Type Stocks to Buy Right Now
These stocks are good value buys for the long haul. 
Via The Motley Fool
Five Best And Worst Performing Healthcare Stocks In December 2022
Multiple factors are expected to help the healthcare industry overcome inflationary pressures. If you are looking to invest in this sector, then to help you select, here are the five best and worst... 
Via Talk Markets
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
Via Benzinga
Is Exelixis Stock a Buy Now?
Don't be too quick to dismiss this company as a one-trick pony. 
Via The Motley Fool
This House of Representative Just Sold Up To $250K In Bristol-Myers Squibb Stock
Via Benzinga
The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation to Expand with Amgen’s Commitment of $8 Million
From Bristol Myers Squibb
Via Business Wire
5 Stocks You Can Confidently Invest $500 in Right Now
Any investor with $500 can buy these stocks with conviction. 
Via The Motley Fool
Neurodegenerative Diseases Focused Company Goes Public Via Wilbur Ross-Backed SPAC, Joins Alzheimer's Race To Compete Biogen
Via Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
Bristol Myers Squibb Wins Another Approval for Its Multimillion-Dollar Cancer Drug
A cutting-edge cancer treatment from the drugmaker was recently approved in Japan to treat a type of lymphoma. 
Via The Motley Fool
7 Dividend-Paying Large-Cap Stocks to Buy in January
Now's the time to load up on these seven dividend-paying large-cap stocks, each of which has a forward dividend yield of at least 3%. 
Via InvestorPlace
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
These three healthcare stocks all deliver dependable dividends, with yields of 3% or more. 
Via The Motley Fool
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish
2023 can be the year of biotechs after two consecutive years of negative or barely positive returns. 
Via Talk Markets
Is Alexandria Real Estate Equity a Buy?
It's a great stock, but investors dislike the sector. 
Via The Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace
Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive
Via Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
Someone with a lot of money to spend has taken a bullish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Investors Should Consider This Warren Buffett Advice in 2023
If investors wait too long to buy stocks, they're in danger of missing out on the inevitable rally. 
Via The Motley Fool
20 Recession-Proof Stocks to Buy Now for 2023
These recession-proof stocks typically hold up better in a recession and add diversity to your portfolio. 
Via The Motley Fool
Congressman Sells Stocks At End Of 2022 And Retires From Office: Taking Profits Or Warning Sign?
A member of Congress sold out of his positions in several stocks at the end of 2022. The move came as he finished his term serving the state of Texas and announced his retirement. 
Via Benzinga
Bristol Myers Squibb to Present at J.P. Morgan’s 41st Annual Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York
From Bristol Myers Squibb
Via Business Wire
23 Top Dividend Stocks to Buy and Hold in 2023
These dividend stocks could reward investors in the new year and beyond. 
Via The Motley Fool
See a Recession in 2023? Stock Up on These 3 Ultra-Safe Dividend Stocks.
These dividend stocks should easily withstand a recession. 
Via The Motley Fool
You Can Boost Your Passive Income With These 3 Dividend Raises
A trio of top companies in the agricultural machinery, waste removal, and pharmaceutical industries recently enhanced their shareholder payouts. 
Via The Motley Fool
The Top Healthcare Stocks to Buy With $100
Healthcare is a sector that has proven to be reliable in recessions. 
Via The Motley Fool
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
65 66 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.